2 ms·
Bay Area biotech company Synthego, raised $392M, forced into bankruptcy
- hoseyor 1y agoI wonder if that was private lending/credit. There seems to be a huge issue building in that unregulated space.
- duxup 1y agoBiotech seems to historically require a lot of iterations / failures before breakthroughs happen. I'm not sure the typical VC "startup" type expectations / speed really lends itself to that kind of business.